BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin CT, Hsueh PR, Wu SJ, Yao M, Ko BS, Li CC, Hsu CA, Tang JL, Tien HF. Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial. Biol Blood Marrow Transplant 2018;24:2310-5. [PMID: 30026110 DOI: 10.1016/j.bbmt.2018.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ho DY, Enriquez K, Multani A. Herpesvirus Infections Potentiated by Biologics. Infect Dis Clin North Am 2020;34:311-39. [PMID: 32444012 DOI: 10.1016/j.idc.2020.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 McVoy MM, Tenorio E, Kauvar LM. A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I). Int J Mol Sci 2018;19:E3982. [PMID: 30544903 DOI: 10.3390/ijms19123982] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]